Metronidazole 250 MG Oral Tablet — RxCUI 314106
RxNorm drug concept · Semantic clinical drug
RxCUI 314106
Semantic clinical drug · SCD
● Current RxNorm concept 59 FDA products
188 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI314106
Official nameMetronidazole 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped59
Package NDCs mapped188
Reported Medicaid activity (SDUD)2,448,887 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Metronidazole Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Metronidazole Injection is an IV antibiotic for serious infections caused by anaerobic bacteria, such as abdominal, bloodstream, lung, bone, brain or gynecologic infections. It can...
- It's given through a vein as a slow drip, usually by your care team. You'll often get a first larger dose and then repeat doses about every six hours. Your doctor may later switch...
- The more common ones are nausea, vomiting, diarrhea, stomach cramps, a metallic taste and headache. Some people also have irritation at the IV site. Let your nurse know if it bothe...
- Tell your team right away about confusion, dizziness, trouble with balance or speech, seizures, or numbness or tingling in your hands or feet. Also report a severe rash, blistering...
🕸️ Concept Web — How Metronidazole 250 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Metronidazole 250 MG Oral Tablet
RxCUI 314106 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Metronidazole
6922IN
-
Metronidazole
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metronidazole Oral Tablet
372897SCDF -
Metronidazole Oral Product
1164083SCDG -
Metronidazole Pill
1164084SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Metronidazole Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metronidazole 250 MG
316300SCDC
-
Metronidazole 250 MG
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
-
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack [Helidac Therapy]
758020BPCK -
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack
758019GPCK
-
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack [Helidac Therapy]
Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metronidazole 250 MG
SCDC · 316300 -
Metronidazole Oral Tablet
SCDF · 372897 -
Metronidazole Oral Product
SCDG · 1164083 -
Metronidazole Pill
SCDG · 1164084 -
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack
GPCK · 758019
Brand-Name Concepts
-
{112 (bismuth subsalicylate 262 MG Chewable Tablet) / 56 (metronidazole 250 MG Oral Tablet) / 56 (tetracycline hydrochloride 500 MG Oral Capsule) } Pack [Helidac Therapy]
BPCK · 758020
📦 FDA Products & Package NDCs
59 products · 188 package NDCs
188 package NDCs map to RxCUI 314106 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-7126-61 | 100 BLISTER PACK in 1 CARTON (0904-7126-61) / 1 TABLET in 1... | Metronidazole | Major Pharmaceuticals | 2017-11-29 |
| 00904-7156-61 | 100 BLISTER PACK in 1 CARTON (0904-7156-61) / 1 TABLET in 1... | Metronidazole | Major Pharmaceuticals | 2017-11-29 |
| 15955-0388-01 | 100 TABLET in 1 BOTTLE (15955-388-01) | Metronidazole | Alembic Labs LLC | 2019-06-26 |
| 15955-0388-05 | 500 TABLET in 1 BOTTLE (15955-388-05) | Metronidazole | Alembic Labs LLC | 2019-06-26 |
| 15955-0389-01 | 100 TABLET in 1 BOTTLE (15955-389-01) | Metronidazole | Alembic Labs LLC | 2019-06-26 |
| 15955-0389-05 | 500 TABLET in 1 BOTTLE (15955-389-05) | Metronidazole | Alembic Labs LLC | 2019-06-26 |
| 16571-0664-01 | 100 TABLET in 1 BOTTLE (16571-664-01) | Metronidazole | Rising Pharma Holdings, Inc. | 2015-05-29 |
| 16571-0664-50 | 500 TABLET in 1 BOTTLE (16571-664-50) | Metronidazole | Rising Pharma Holdings, Inc. | 2015-05-29 |
| 16571-0665-01 | 100 TABLET in 1 BOTTLE (16571-665-01) | Metronidazole | Rising Pharma Holdings, Inc. | 2015-05-29 |
| 16571-0665-50 | 500 TABLET in 1 BOTTLE (16571-665-50) | Metronidazole | Rising Pharma Holdings, Inc. | 2015-05-29 |
| 23155-0651-01 | 100 TABLET in 1 BOTTLE, PLASTIC (23155-651-01) | Metronidazole | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2017-11-29 |
| 23155-0651-05 | 500 TABLET in 1 BOTTLE, PLASTIC (23155-651-05) | Metronidazole | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2017-11-29 |
| 23155-0652-01 | 100 TABLET in 1 BOTTLE, PLASTIC (23155-652-01) | Metronidazole | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2017-11-29 |
| 23155-0652-05 | 500 TABLET in 1 BOTTLE, PLASTIC (23155-652-05) | Metronidazole | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2017-11-29 |
| 29300-0226-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-226-01) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0226-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-226-05) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0226-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-226-10) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0226-46 | 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-226-46) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0226-52 | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-226-52) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0227-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-227-01) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0227-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-227-05) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0227-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-227-10) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 29300-0227-46 | 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-227-46) | Metronidazole | Unichem Pharmaceuticals (USA), Inc. | 2014-06-01 |
| 43063-0719-06 | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-719-06) | Metronidazole | PD-Rx Pharmaceuticals, Inc. | 2016-11-02 |
| 43063-0719-21 | 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-719-21) | Metronidazole | PD-Rx Pharmaceuticals, Inc. | 2017-05-01 |
| 43063-0719-28 | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-719-28) | Metronidazole | PD-Rx Pharmaceuticals, Inc. | 2017-05-03 |
| 43063-0719-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-719-30) | Metronidazole | PD-Rx Pharmaceuticals, Inc. | 2016-10-24 |
| 43063-0719-56 | 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-719-56) | Metronidazole | PD-Rx Pharmaceuticals, Inc. | 2018-04-05 |
| 46708-0428-30 | 30 TABLET in 1 BOTTLE (46708-428-30) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0428-31 | 100 TABLET in 1 BOTTLE (46708-428-31) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0428-50 | 50 TABLET in 1 BOTTLE (46708-428-50) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0428-61 | 250 TABLET in 1 BOTTLE (46708-428-61) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0428-71 | 500 TABLET in 1 BOTTLE (46708-428-71) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0428-91 | 1000 TABLET in 1 BOTTLE (46708-428-91) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0429-30 | 30 TABLET in 1 BOTTLE (46708-429-30) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0429-31 | 100 TABLET in 1 BOTTLE (46708-429-31) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0429-50 | 50 TABLET in 1 BOTTLE (46708-429-50) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0429-71 | 500 TABLET in 1 BOTTLE (46708-429-71) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 46708-0429-91 | 1000 TABLET in 1 BOTTLE (46708-429-91) | Metronidazole | Alembic Pharmaceuticals Limited | 2016-12-01 |
| 50090-0201-00 | 21 TABLET, FILM COATED in 1 BOTTLE (50090-0201-0) | Metronidazole | A-S Medication Solutions | 2016-06-21 |
| 50090-0201-01 | 28 TABLET, FILM COATED in 1 BOTTLE (50090-0201-1) | Metronidazole | A-S Medication Solutions | 2014-11-28 |
| 50090-0201-02 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-0201-2) | Metronidazole | A-S Medication Solutions | 2014-11-28 |
| 50090-5691-00 | 21 TABLET in 1 BOTTLE (50090-5691-0) | Metronidazole | A-S Medication Solutions | 2021-09-21 |
| 50090-5691-01 | 28 TABLET in 1 BOTTLE (50090-5691-1) | Metronidazole | A-S Medication Solutions | 2021-09-21 |
| 50090-5691-02 | 30 TABLET in 1 BOTTLE (50090-5691-2) | Metronidazole | A-S Medication Solutions | 2021-09-21 |
| 50111-0333-01 | 100 TABLET in 1 BOTTLE (50111-333-01) | Metronidazole | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 50111-0333-02 | 500 TABLET in 1 BOTTLE (50111-333-02) | Metronidazole | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 50111-0333-06 | 250 TABLET in 1 BOTTLE (50111-333-06) | Metronidazole | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 50111-0334-01 | 100 TABLET in 1 BOTTLE (50111-334-01) | Metronidazole | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 50111-0334-02 | 500 TABLET in 1 BOTTLE (50111-334-02) | Metronidazole | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
Observed labelers:
Bryant Ranch Prepack (40) ·
Asclemed USA, Inc. (14) ·
Alembic Pharmaceuticals Inc. (11) ·
Alembic Pharmaceuticals Limited (11) ·
Aurobindo Pharma Limited (9) ·
Method Pharmaceuticals LLC (9)
· +25 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.